ASPIRE: Aspirin good option for extended treatment of VTE

ASPIRE: Aspirin good option for extended treatment of VTE
Dr Timothy Brighton (Prince of Wales Hospital, Sydney, Australia) reported the Aspirin to Prevent Recurrent Venous Thromboembolism (ASPIRE) study at the late-breaking clinical-trials sessions here at the American Heart Association 2012 Scientific …

Full News here – Read more on TheHeart.Org

Leave a Reply